1-苄氧羰基-3-羟基氮杂环丁烷 | 128117-22-6

• 物质功能分类: 医药中间体
• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 1-苄氧羰基-3-羟基氮杂环丁烷
• 中文别名: 3-羟基-氮杂环丁烷-1-甲酸苄酯；N-Cbz-3-羟基氮杂丁烷；1-Cbz-3-羟基氮杂环丁烷；1-CBZ-3-羟基氮杂环丁烷
• 英文名称: benzyl 3-hydroxyazetidine-1-carboxylate
• 英文别名: 1-N-Cbz-3-hydroxyazetidine；1-Cbz-3-hydroxyazetidine；1-Benzyloxycarbonyl-3-hydroxyazetidine
• CAS: 128117-22-6
• 化学式: C₁₁H₁₃NO₃
• mdl: MFCD09037849
• 分子量: 207.229
• InChiKey: XJWSNDGCJMGHSR-UHFFFAOYSA-N

物化性质

• 沸点：
  356.7±42.0 °C(Predicted)
• 密度：
  1.317
• 闪点：
  169.5℃

计算性质

• 辛醇/水分配系数(LogP)：
  0.8
• 重原子数：
  15
• 可旋转键数：
  3
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.363
• 拓扑面积：
  49.8
• 氢给体数：
  1
• 氢受体数：
  3

安全信息

• 危险性防范说明：
  P261,P305+P351+P338
• 危险性描述：
  H315,H319,H335
• 储存条件：
  2-8°C

SDS

Material Safety Data Sheet

---

Section 1. Identification of the substance
Product Name: 1-Cbz-3-(hydroxy)azetidine
Synonyms:

---

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

---

Section 3. Composition/information on ingredients.
Ingredient name: 1-Cbz-3-(hydroxy)azetidine
CAS number: 128117-22-6

---

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

---

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

---

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

---

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels.
Storage:

---

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

---

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C11H13NO3
Molecular weight: 207.2

---

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides.

---

Section 11. Toxicological information
No data.

---

Section 12. Ecological information
No data.

---

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

---

Section 14. Transportation information
Non-harzardous for air and ground transportation.

---

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

制备方法与用途

1-Cbz-3-羟基氮杂环丁烷是一种不可切割的ADC连接物，用于合成抗体药物偶联物(ADC)。此外，它也是一种基于烷基链的PROTAC连接剂，可用于合成PROTAC。

反应信息

• 作为反应物：
  描述：

  1-苄氧羰基-3-羟基氮杂环丁烷 在 三乙胺 、 sodium iodide 作用下， 以 二氯甲烷 、 N,N-二甲基甲酰胺 为溶剂， 反应 2.0h， 生成 3-碘氮杂丁烷-1-羧酸苄酯
  参考文献：
  名称：

  非活化仲烷基卤化物与炔基格氏试剂的轻度和无磷铁催化交叉偶联

  摘要：

  已经开发出一种简单的方案，用于在室温下将非活化的仲烷基溴化物和碘化物与炔基格氏试剂进行铁催化的交叉偶联。宽范围的仲烷基卤化物和末端炔烃是可接受的，以高收率提供了取代的炔烃。反应方案的略微修改也允许与多种伯烷基卤化物交叉偶联。

  DOI：

  10.1021/ol501087m
• 作为产物：
  描述：

  3-羟基氮杂环丁烷盐酸盐 以33的产率得到1-苄氧羰基-3-羟基氮杂环丁烷
  参考文献：
  名称：

  2-(4-bromo or 4-iodo phenylamino) benzoic acid derivatives

  摘要：

  苯胺基苯甲酸，苯甲酰胺和苄醇衍生物的化学式，其中R1，R2，R3，R4，R5和R6为氢或取代基，例如烷基，而R7为氢或有机基团，Z为COOR7，四唑基，CONR6R7或CH2OR7，是MEK的有效抑制剂，因此可用于治疗癌症和其他增殖性疾病，如炎症，牛皮癣和再狭窄，以及中风，心力衰竭和免疫缺陷病。

  公开号：

  US07019033B2

文献信息

• BRM TARGETING COMPOUNDS AND ASSOCIATED METHODS OF USE
  申请人：Arvinas Operations, Inc.

  公开号：US20190300521A1

  公开（公告）日：2019-10-03

  The present disclosure relates to bifunctional compounds, which find utility as modulators of SMARCA2 or BRM (target protein). In particular, the present disclosure is directed to bifunctional compounds, which contain on one end a ligand that binds to the Von Hippel-Lindau E3 ubiquitin ligase, and on the other end a moiety which binds the target protein, such that the target protein is placed in proximity to the ubiquitin ligase to effect degradation (and inhibition) of target protein. The present disclosure exhibits a broad range of pharmacological activities associated with degradation/inhibition of target protein. Diseases or disorders that result from aggregation or accumulation of the target protein are treated or prevented with compounds and compositions of the present disclosure.

  本公开涉及双功能化合物，其作为SMARCA2或BRM（靶蛋白）的调节剂具有实用性。具体而言，本公开涉及包含一端结合Von Hippel-Lindau E3泛素连接酶的配体，另一端结合靶蛋白的双功能化合物，使得靶蛋白与泛素连接酶靠近以实现靶蛋白的降解（和抑制）。本公开展示了与靶蛋白降解/抑制相关的广泛药理活性。本公开的化合物和组合物用于治疗或预防由靶蛋白聚集或积累导致的疾病或紊乱。
• Synthesis of 3,3-Diarylazetidines by Calcium(II)-Catalyzed Friedel–Crafts Reaction of Azetidinols with Unexpected Cbz Enhanced Reactivity
  作者：Camille Denis、Maryne A. J. Dubois、Anne Sophie Voisin-Chiret、Ronan Bureau、Chulho Choi、James J. Mousseau、James A. Bull

  DOI：10.1021/acs.orglett.8b03745

  日期：2019.1.4

  Azetidines are valuable motifs that readily access under explored chemical space for drug discovery. 3,3-Diarylazetidines are prepared in high yield from N-Cbz azetidinols in a calcium(II)-catalyzed Friedel–Crafts alkylation of (hetero)aromatics and phenols, including complex phenols such as β-estradiol. Electron poor phenols undergo O-alkylation. The product azetidines can be derivatized to drug-like

  氮杂环丁烷是有价值的基序，可以很容易地在探索的化学空间中用于药物发现。3,3-二芳基氮杂环丁烷是由N -Cbz氮杂环丁醇以钙（II）催化的（杂）芳族化合物和酚（包括复杂的酚，例如β-雌二醇）的Friedel-Crafts烷基化反应制得的。电子贫酚会发生O-烷基化。产物氮杂环丁烷可以通过氮杂环丁烷氮和芳族基团衍生为药物样化合物。该Ñ -Cbz组是由四元环上提供中间碳阳离子的稳定化反应性的，以关键。
• [EN] N-ACYL AMINO ACID COMPOUNDS AND METHODS OF USE<br/>[FR] COMPOSÉS D'ACIDES AMINÉS N-ACYLE ET MÉTHODES D'UTILISATION
  申请人：PLIANT THERAPEUTICS INC

  公开号：WO2018049068A1

  公开（公告）日：2018-03-15

  The invention relates to compounds of formula (I), or a salt thereof wherein R1, A, L, and R2 and n are as described herein. Compounds of formula (I) and pharmaceutical compositions thereof are ανβ1 integrin inhibitors that are useful for treating tissue specific fibrosis.

  该发明涉及式(I)的化合物或其盐，其中R1、A、L、R2和n如本文所述。式(I)的化合物及其药物组成物是ανβ1整合素抑制剂，可用于治疗特定组织纤维化。
• Zn- and Cu-Catalyzed Coupling of Tertiary Alkyl Bromides and Oxalates to Forge Challenging C–O, C–S, and C–N Bonds
  作者：Yuxin Gong、Zhaodong Zhu、Qun Qian、Weiqi Tong、Hegui Gong

  DOI：10.1021/acs.orglett.0c04206

  日期：2021.2.5

  We describe here the facile construction of sterically hindered tertiary alkyl ethers and thioethers via the Zn(OTf)2-catalyzed coupling of alcohols/phenols with unactivated tertiary alkyl bromides and the Cu(OTf)2-catalyzed thiolation of unactivated tertiary alkyl oxalates with thiols. The present protocol represents one of the most effective unactivated tertiary C(sp3)–heteroatom bond-forming conditions

  我们在这里描述了通过Zn（OTf）2催化的醇/酚与未活化的叔烷基溴化物和Cu（OTf）2催化的未活化的叔烷基草酸酯与硫醇的空间位阻叔烷基醚和硫醚的简便构建。。本协议代表了最有效的未激活的叔C（sp 3）-杂原子键形成条件，这是通过易于获得的路易斯酸催化作用而开发的，该条件出奇的少。
• BENZOTHIOPHENE DERIVATIVE
  申请人：DAIICHI SANKYO COMPANY, LIMITED

  公开号：US20160024060A1

  公开（公告）日：2016-01-28

  [Problem to be Solved] It is intended to provide a compound having PDE10A inhibitory activity and having a novel structure, or an isotope thereof or a pharmaceutically acceptable salt thereof, and a pharmaceutical composition comprising the same as an active ingredient. [Solution] The present invention provides a compound represented by the general formula (I) or a pharmaceutically acceptable salt thereof.

  [待解决问题] 旨在提供一种具有PDE10A抑制活性的化合物，并具有新颖结构，或其同位素或药用可接受盐，以及一种以该化合物作为活性成分的药物组合物。 [解决方案] 本发明提供了一种由通用公式（I）表示的化合物或其药用可接受盐。